Search Ontology:
ChEBI

etodolac

Term ID
CHEBI:4909
Synonyms
  • (+-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
  • (1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid
  • (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
  • 1,3,4,9-tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
  • 1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
  • 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
  • ETODOLAC
  • etodolaco
  • etodolacum
  • ETODOLIC ACID
Definition
A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
References
  • cas:41340-25-4
  • drugbank:DB00749
  • drugcentral:1103
  • hmdb:HMDB0014887
  • kegg.drug:D00315
  • lincs.smallmolecule:LSM-1781
  • patent:DE2301525
  • patent:US3939178
  • pubmed:15369391
  • pubmed:2527995
  • pubmed:28166217
  • pubmed:2970548
  • wikipedia.en:Etodolac
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from etodolac
Phenotype where environments contain etodolac
Phenotype modified by environments containing etodolac
Phenotype affecting etodolac
Human Disease Model